MLchartDataset catalogue

recombinant MAGE-3.1 antigen

Term · Oncology and biomedicine · MLC-T-ONC-016446

A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma.

Table 1. Record
IdentifierMLC-T-ONC-016446
FieldOncology and biomedicine
SynonymsMAGE-3.1; MAGEA3; MAGE-3
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016446",
  "term": "recombinant MAGE-3.1 antigen",
  "field": "Oncology and biomedicine",
  "definition": "A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma.",
  "synonyms": [
    "MAGE-3.1",
    "MAGEA3",
    "MAGE-3"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/recombinant-mage-3-1-antigen/"
}

Record 14,196 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.